Biogen INC BIOGEN INC ORD SHS/ US09062X1037 /
| 15.11.2024 20:08:36 | Diff. -5,79 | Volumen | Geld- | Brief- | Marktkapitalisierung | Dividendenr. | KGV |
|---|---|---|---|---|---|---|---|
| 160,38USD | -3,48% | 9.929 Umsatz: 1,61 Mio. |
-Geld Vol: - | -Brief Vol: - | 23,31 Mrd.USD | - | 19,95 |
Aktiva
| 2014 US GAAP in Mio. USD |
2015 US GAAP in Mio. USD |
2016 US GAAP in Mio. USD |
2017 US GAAP in Mio. USD |
2018 US GAAP in Mio. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sachanlagen | 1.765,6830 | 2.187,6000 | 2.501,8000 | 3.182,4000 | 3.601,2000 | ||||||
| Immaterielle Vermögensgegenstände | 4.028,5070 | 4.085,1000 | 3.808,3000 | 3.879,6000 | 3.120 | ||||||
| Finanzanlagen | 1.470,6520 | 2.760,4000 | 2.829,4000 | 3.057,3000 | 1.375,9000 | ||||||
| Anlagevermögen | 9.643,8860 | 12.804,5000 | 14.144,6000 | 15.779,3000 | 17.648 | ||||||
| Vorräte | 804,0220 | 893,4000 | 1.001,6000 | 902,7000 | 929,9000 | ||||||
| Forderungen | 1.292,4450 | 1.227 | 1.441,6000 | 1.787 | 1.958,5000 | ||||||
| Liquide Mitteln | 1.204,9240 | 1.308 | 2.326,5000 | 1.573,8000 | 1.224,6000 | ||||||
| Umlaufvermögen | 4.672,6730 | 6.700,3000 | 8.732,2000 | 7.873,3000 | 7.640,9000 | ||||||
| Aktiva, gesamt | 14.316,5590 | 19.504,8000 | 22.876,8000 | 23.652,6000 | 25.288,9000 | ||||||
Passiva
| 2014 US GAAP in Mio. USD |
2015 US GAAP in Mio. USD |
2016 US GAAP in Mio. USD |
2017 US GAAP in Mio. USD |
2018 US GAAP in Mio. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Verbindlichkeiten aus Lieferungen und Leistungen | 229,1780 | 267,4000 | 279,8000 | 395,5000 | 370,5000 | ||||||
| Langfristige Schulden | 582,0610 | 6.521,5000 | 6.512,7000 | 5.935 | 5.936,5000 | ||||||
| Verbindlichkeiten gegenüber Kreditinstituten | 582,1000 | 6.521,5000 | 6.512,7000 | 5.935 | 5.936,5000 | ||||||
| Rückstellungen | 218,8000 | 333,6000 | 325 | 190,8000 | 1.699,7000 | ||||||
| Verbindlichkeiten | 3.502,5190 | 10.129,9000 | 10.748,2000 | 11.054,5000 | 12.257,3000 | ||||||
| Gezeichnetes Kapital | ,1290 | ,1000 | ,1000 | ,1000 | ,1000 | ||||||
| Eigenkapital | 10.814,0400 | 9.374,9000 | 12.128,6000 | 12.598,1000 | 13.031,6000 | ||||||
| Minderheitenanteile | 5,0300 | 2,1000 | -11,5000 | -14,7000 | -8 | ||||||
| Passiva, gesamt | 14.316,5590 | 19.504,8000 | 22.876,8000 | 23.652,6000 | 25.288,9000 | ||||||
Gewinn- und Verlustrechnung
| 2014 US GAAP in Mio. USD |
2015 US GAAP in Mio. USD |
2016 US GAAP in Mio. USD |
2017 US GAAP in Mio. USD |
2018 US GAAP in Mio. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Umsatzerlöse | 9.703,3240 | 10.763,8000 | 11.448,8000 | 12.273,9000 | 13.452,9000 | ||||||
| Abschreibungen (Gesamt) | 688,1500 | 600,4000 | 682,7000 | 1.081 | 1.016,6000 | ||||||
| Betriebsergebnis | 3.972,4140 | 4.891 | 5.150,4000 | 5.344,2000 | 5.888,6000 | ||||||
| Zinsergebnis | -17,3000 | -73,4000 | -196,6000 | -172,3000 | -88,1000 | ||||||
| Ergebnis vor Steuern | 3.946,6330 | 4.767,3000 | 4.933 | 5.128,8000 | 5.899,6000 | ||||||
| Ertragsteuern | 989,9420 | 1.161,6000 | 1.237,3000 | 2.458,7000 | 1.425,6000 | ||||||
| Gewinnanteil Minderheitsgesellschafter | 6,7810 | 46,2000 | -7,1000 | 131 | 43,3000 | ||||||
| Konzernjahresüberschuss | 2.934,7840 | 3.547 | 3.702,8000 | 2.539,1000 | 4.430,7000 | ||||||
Pro Aktie
Cash Flow
| 2014 US GAAP in Mio. USD |
2015 US GAAP in Mio. USD |
2016 US GAAP in Mio. USD |
2017 US GAAP in Mio. USD |
2018 US GAAP in Mio. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow aus laufender Geschäftstätigkeit | 2.942,1150 | 3.716,1000 | 4.522,4000 | 4.551 | 6.187,7000 | ||||||
| Cash Flow aus Investitionstätigkeit | -1.542,9760 | -4.553,6000 | -2.484,8000 | -2.963,1000 | -2.046,3000 | ||||||
| Cash Flow aus Finanzierungstätigkeit | -755,8730 | 986,4000 | -987,8000 | -2.380 | -4.472 | ||||||
| Veränderung der liquiden Mittel | 643,2660 | 148,9000 | 1.049,8000 | -792,1000 | -330,6000 | ||||||
| Anzahl der Mitarbeiter | 7.550 | 7.350 | 7.400 | 7.300 | 7.800 | ||||||
